Company Filing History:
Years Active: 2002-2010
Title: **Inventor Profile: Christian C. Fritz**
Introduction
Christian C. Fritz is an esteemed inventor based in Natick, MA, United States. With an impressive portfolio of 13 patents, Fritz has made significant contributions to the fields of pharmaceutical innovations and antibacterial research. His work focuses on developing compounds and methods that can have a profound impact on treating various health disorders.
Latest Patents
Christian C. Fritz's latest patents include groundbreaking research on compounds designed to inhibit the interaction of BCL proteins with their binding partners. One aspect of his invention relates to heterocyclic compounds that specifically bind to BCL proteins, thereby inhibiting their function. This innovation provides promising methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
In addition to his work on BCL proteins, Fritz has also explored essential bacterial genes and polypeptides. His patent discloses genes termed 'S-ylqF,' 'S-yqeG,' 'S-yybQ,' 'S-yerL,' and 'S-ysxC,' which are crucial for the survival of a variety of bacteria. The genes and their corresponding polypeptides are potential candidates for identifying antibacterial agents to tackle a broad spectrum of bacterial infections.
Career Highlights
Christian C. Fritz has gained valuable industry experience working with notable companies such as Millennium Pharmaceuticals Limited and Infinity Pharmaceuticals, Inc. His contributions in these organizations have further solidified his reputation as a notable figure in the pharmaceutical field.
Collaboration
Fritz has collaborated with talented individuals, including Philip Youngman and Luz-Maria Guzman. Guzman brings a unique perspective as one of the influential female voices in the innovative pursuits they have undertaken together.
Conclusion
Christian C. Fritz stands out as a distinguished inventor whose contributions have the potential to transform the landscape of medical treatment and antibacterial strategies. With a track record of innovative patents and significant collaborations, he continues to inspire the next generation of inventors and researchers in the realm of pharmaceuticals.